Protheragen Expands Global GLP-1 Agonist API Supply to Ease FDA-Listed Shortages
Protheragen announced an expanded global supply of GLP-1 agonist APIs to meet rising demand for diabetes and obesity treatments. New York, United States, September 23, 2025 — Protheragen, an ISO9001-certified supplier of pharmaceutical ingredients and… Read More »Protheragen Expands Global GLP-1 Agonist API Supply to Ease FDA-Listed Shortages





